Cite
Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients
MLA
Tomohiro Izumisawa, et al. “Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients.” Biological and Pharmaceutical Bulletin, vol. 42, Dec. 2019, pp. 2089–94. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f874684af2b6a7185d7f3732d6d2f01&authtype=sso&custid=ns315887.
APA
Tomohiro Izumisawa, Tetsuya Horino, Tomoyoshi Kaneko, Masakazu Soma, Noriko Takahashi, Masahiko Imai, Hideo Hasegawa, & Nobuyuki Wakui. (2019). Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients. Biological and Pharmaceutical Bulletin, 42, 2089–2094.
Chicago
Tomohiro Izumisawa, Tetsuya Horino, Tomoyoshi Kaneko, Masakazu Soma, Noriko Takahashi, Masahiko Imai, Hideo Hasegawa, and Nobuyuki Wakui. 2019. “Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients.” Biological and Pharmaceutical Bulletin 42 (December): 2089–94. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f874684af2b6a7185d7f3732d6d2f01&authtype=sso&custid=ns315887.